CVS Health stock trades at USD 85.21 as Q2 revenue rises 7.3 percent

Published on 09/25/2026 at 16:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On September 25, 2026, CVS Health stock stood at USD 85.21, up 0.19 percent from the prior close. Q2 revenue rose 7.3 percent to USD 106.10 billion.

Moderner Apothekenverkaufsraum mit Apothekerin und Kundin vor Medikamentenregalen — CVS Health Corp. zeigt fotorealen Apothekenverkaufsraum mit Apothekerin und Kundin, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health stock (ISIN US1266501006) was trading at USD 85.21 on the NYSE on September 25, 2026, at 10:06 a.m. ET, up 0.19 percent from the prior close of USD 85.05. The latest quarterly picture combines revenue growth with higher analyst targets and raised fiscal guidance.

Q2 revenue reaches USD 106.10 billion

According to Yahoo Finance, CVS Health generated USD 106.10 billion in Q2 2026 revenue, an increase of 7.3 percent from the year-ago quarter. Adjusted earnings per share came in at USD 2.58, up 42.5 percent year over year, while revenue exceeded consensus by 5.91 percent.

The company also lifted fiscal 2026 adjusted EPS guidance from USD 7.30-7.50 to USD 7.90-8.10. The revenue outlook moved from at least USD 405 billion to at least USD 414 billion, giving investors a clearer benchmark for the rest of the year.

Analysts keep targets above USD 100

As Investing.com reports, UBS reiterated a Buy rating and a USD 118 price target. The same report says Bernstein raised its target from USD 106 to USD 112, citing a faster expected recovery at Aetna.

For valuation context, the USD 118 UBS target stands USD 32.79 above the September 25 trading price. That gap is 38.48 percent of the current share price, while the stock remains below its 52-week high of USD 110.68.

Stock stays inside its yearly range

CVS Health traded between USD 84.70 and USD 85.83 during the September 25 session. Its 52-week range is USD 69.51 to USD 110.68, and the company carries a market capitalization of USD 108,721,995,300 as of the same quote.

The market is weighing two separate signals: Q2 adjusted EPS of USD 2.58 and the higher fiscal outlook support the earnings case, while the share price is still USD 25.47 below the 52-week high. The next useful checkpoint is whether the raised USD 7.90-8.10 adjusted EPS range translates into sustained operating improvement.

CVS Health stock trades at USD 85.21

CVS Health stock was trading at USD 85.21 on the NYSE on September 25, 2026, at 10:06 a.m. ET. The session change was positive at 0.19 percent, with volume of 618,979 shares.